Amgen Inc is > 10% Shareholder of Vigil Neuroscience, Inc.. Currently has a direct ownership of 3.21 Million shares of VIGL, which is worth approximately $11.3 Million. The most recent transaction as insider was on Jan 11, 2022, when has been sold 3,206,281 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.21M
0% 3M change
0% 12M change
Total Value Held $11.3 Million

AMGEN INC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 11 2022
BUY
Conversion of derivative security
-
3,206,281 Added 50.0%
3,206,281 Common Stock

Also insider at

BGNE
BeiGene, Ltd. Healthcare
NMRA
Neumora Therapeutics, Inc.
AI

Amgen Inc

> 10% Shareholder
Thousand Oaks, CA

Track Institutional and Insider Activities on VIGL

Follow Vigil Neuroscience, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIGL shares.

Notify only if

Insider Trading

Get notified when an Vigil Neuroscience, Inc. insider buys or sells VIGL shares.

Notify only if

News

Receive news related to Vigil Neuroscience, Inc.

Track Activities on VIGL